Pretreatment Attrition, Treatment Delay and Treatment Outcome in Drug-Resistant Tuberculosis: A Mixed-Methods Cohort Study in Public and Private Hospitals in Indonesia
- 1Department of Pulmonology and Respiratory Medicine, Faculty of Medicine Universitas Indonesia - Persahabatan Central General Hospital
Abstract
BackgroundDrug-resistant tuberculosis (DR-TB) remains a major problem in Indonesia, with a significant low treatment initiation rate. This study identifies factors influencing treatment initiation and assess the impact of delay on patient outcomes.
MethodsWe conducted a mixed-methods study using a parallel convergent design. The quantitative component analyzed the Tuberculosis Information System (TBIS) data from three hospitals in Jakarta and Bogor from January 2022 to December 2023. The qualitative component involved in-depth interviews and Focus Group Discussions (FGD) with DR-TB patients, healthcare workers, patient supporters, and program managers.
ResultsAmong 1,665 people with DR-TB included in this study, we found a pre- treatment attrition rate of 6.4%. We identified two factors of pre-treatment attrition: prior TB treatment (aOR=1.7, 95%CI 1.082-2.671) and distance to hospital (aOR=1.9, 95%CI: 1.136-3.180). Conversely, referred patients, treatment in suburban areas, and people with rifampicin-resistant (RR)-TB were 85%, 82%, and 63% less likely to experience attrition, respectively. Qualitative findings identify patient, social, and health system barriers to the treatment initiation, and alternative remedies emerged as a coping mechanism.
ConclusionStrengthening referral systems, decentralizing care, and addressing socio- economic barriers are critical for ensuring timely DR-TB treatment initiation.
Related
- Treatment outcomes and post-treatment mortality among people with multidrug/rifampicin-resistant tuberculosis in Sierra Leone: a national cohort study
- Drivers of drug-resistant tuberculosis treatment initiation delay at three tertiary health facilities in Uganda: A mixed-methods study
- Early sputum bacterial load dynamics predict treatment response in multidrug-resistant/rifampicin-resistant tuberculosis: A multicenter prospective cohort study
- Household contact management of drug-resistant tuberculosis: a global cost-effectiveness modelling analysis of expanded preventive treatment by age
- Characteristics and Treatment Outcomes of Patients with Drug-Resistant Tuberculosis in Selected Facilities of O.R. Tambo District Municipality, Eastern Cape, South Africa: A Retrospective Cohort Study.
BibTeX
@misc{azzumar2026pretreatment,
title = {{Pretreatment Attrition, Treatment Delay and Treatment Outcome in Drug-Resistant Tuberculosis: A Mixed-Methods Cohort Study in Public and Private Hospitals in Indonesia}},
author = {F. Azzumar and A. F. Rhamadianti and E. Anugrapaksi and M. P. Wardoyo and A. P. A. Hakiman and L. Z. Putri and N. Sawitri and K. Kemalasari and R. Sutarto and A. Fuady and E. Burhan},
howpublished = {medRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.29.26364370},
url = {https://www.medrxiv.org/content/10.64898/2026.09.29.26364370v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Pretreatment Attrition, Treatment Delay and Treatment Outcome in Drug-Resistant Tuberculosis: A Mixed-Methods Cohort Study in Public and Private Hospitals in Indonesia
AU - F. Azzumar
AU - A. F. Rhamadianti
AU - E. Anugrapaksi
AU - M. P. Wardoyo
AU - A. P. A. Hakiman
AU - L. Z. Putri
AU - N. Sawitri
AU - K. Kemalasari
AU - R. Sutarto
AU - A. Fuady
AU - E. Burhan
PY - 2026
DA - 2026/09/29
PB - medRxiv
DO - 10.64898/2026.09.29.26364370
UR - https://www.medrxiv.org/content/10.64898/2026.09.29.26364370v1
AB - BackgroundDrug-resistant tuberculosis (DR-TB) remains a major problem in Indonesia, with a significant low treatment initiation rate. This study identifies factors influencing treatment initiation and assess the impact of delay on patient outcomes. MethodsWe conducted a mixed-methods study using a parallel convergent design. The quantitative component analyzed the Tuberculosis Information System (TBIS) data from three hospitals in Jakarta and Bogor from January 2022 to December 2023. The qualitative component involved in-depth interviews and Focus Group Discussions (FGD) with DR-TB patients, healthcare workers, patient supporters, and program managers. ResultsAmong 1,665 people with DR-TB included in this study, we found a pre- treatment attrition rate of 6.4%. We identified two factors of pre-treatment attrition: prior TB treatment (aOR=1.7, 95%CI 1.082-2.671) and distance to hospital (aOR=1.9, 95%CI: 1.136-3.180). Conversely, referred patients, treatment in suburban areas, and people with rifampicin-resistant (RR)-TB were 85%, 82%, and 63% less likely to experience attrition, respectively. Qualitative findings identify patient, social, and health system barriers to the treatment initiation, and alternative remedies emerged as a coping mechanism. ConclusionStrengthening referral systems, decentralizing care, and addressing socio- economic barriers are critical for ensuring timely DR-TB treatment initiation.
ER -